Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ₹910 crore ...Middle East

Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of Rs 846 crore for the October-December period of the last fiscal year. Total revenue from operations increased to Rs 8,646 crore during the quarter as compared with Rs 7,979 crore in the year-ago period, the drug firm said in a statement. "Q3 reflected steady execution across Aurobindo's core businesses, supported by stable demand and the strength of our diversified product portfolio in key markets, including the US and Europe," Aurobindo Pharma Vice-Chairman and MD K Nithyananda Reddy said. Growth remained measured, with continued focus on operational discipline and a balanced approach to growth and profitability, he added. "As we progress our strategic initiatives, we remain cautious yet confident in our ability to support sustainable value creation

Hence then, the article about aurobindo pharma q3fy26 results net profit rises 8 to 910 crore was published today ( Monday 09/02/2026 - 06:48 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ₹910 crore )

Also on site :

• Say Goodbye to the Undersea Cable That Made the Global Internet Possible
• Commotion Launches Enterprise AI Operating System Powered by NVIDIA Nemotron™ Open Models to Scale Productivity For Digital Workforces
• RemotePass führt SpendCards ein, um das Chaos bei der Kostenerstattung für globale Teams zu beseitigen